ANP |
atrial natriuretic peptide |
BNP |
brain natriuretic peptide |
CHIP |
clonal haematopoiesis of indeterminate potential |
CKD |
chronic kidney disease |
CRS |
cardiorenal syndrome |
CVD |
cardiovascular disease |
DAMP |
danger-associated molecular pattern |
HDL |
high-density lipoproteins |
HF |
heart failure |
HFpEF |
heart failure with preserved ejection fraction |
HFrEF |
heart failure with reduced ejection fraction |
hs-CRP |
high-sensitivity C-reactive protein |
IL |
interleukin |
LDL |
low-density lipoproteins |
LVH |
left ventricular hypertrophy |
NLRP3 |
nucleotide-binding oligomerisation domain (NOD), leucine rich repeat (LRR)-containing protein 3 |
MV |
microvesicles |
PAMP |
pathogen-associated molecular pattern |
PRR |
pattern recognition receptors |
RRT |
renal replacement therapy |
SASP |
senescence-associated secretory phenotype |
SGLT2 |
sodium glucose co-transporter 2 |
TLR |
Toll-like receptor |
TNF |
tumour necrosis factor |